Coronaviruses have been studied for over 60 years, but have only recently gained 25 notoriety as deadly human pathogens with the emergence of severe respiratory syndrome 26 coronavirus and Middle East respiratory syndrome virus. The rapid emergence of these viruses 27 has demonstrated the need for good models to study severe coronavirus respiratory infection and 28 pathogenesis. There are, currently, different methods and models for the study of coronavirus 29 disease. The available genetic methods for the study and evaluation of coronavirus genetics are 30 reviewed here. There are several animal models, both mouse and alternative animals, for the 31 study of severe coronavirus respiratory disease that have been examined, each with different pros 32 and cons relative to the actual pathogenesis of the disease in humans. A current limitation of 33 these models is that no animal model perfectly recapitulates the disease seen in humans. 34
SUMMARY (Abstract) 24
Coronaviruses have been studied for over 60 years, but have only recently gained 25 notoriety as deadly human pathogens with the emergence of severe respiratory syndrome 26 coronavirus and Middle East respiratory syndrome virus. The rapid emergence of these viruses 27 has demonstrated the need for good models to study severe coronavirus respiratory infection and 28 pathogenesis. There are, currently, different methods and models for the study of coronavirus 29 disease. The available genetic methods for the study and evaluation of coronavirus genetics are 30 reviewed here. There are several animal models, both mouse and alternative animals, for the 31 study of severe coronavirus respiratory disease that have been examined, each with different pros 32 and cons relative to the actual pathogenesis of the disease in humans. A current limitation of 33 these models is that no animal model perfectly recapitulates the disease seen in humans. 34
Through the review and analysis of the available disease models investigators can employ the 35 most appropriate available model to study coronavirus various aspects of pathogenesis and 36 evaluate potential antiviral treatments that may potentially be successful in future treatment and 37 prevention of severe coronavirus respiratory infections. 38
INTRODUCTION 40
Severe acute respiratory syndrome coronavirus (SARS-CoV) is a novel human coronavirus 41 that caused the first major pandemic of the new millennium in 2002 (Baas et al., 2008 42 Drosten et al., 2003) . Bats have been a source of a number of emerging zoonotic diseases, 43
including Nipha and Hindra (Haagmans et al., 2009; Wang et al., 2006) , and the animal source 44 of the novel human SARS-CoV is thought to be Chinese horseshoe bats (Rhinolophus sinicus) 45 (Lau et al., 2010; Wang et al., 2006) . It is believed that a bat coronavirus adapted to infect civet 46 cats and in civet cats the virus further adapted enabling it to infect humans (Lau et al., 2010; Li, 47 IIS restriction enzymes that have been engineered to flank the genomic cDNA insert. Enzyme 140 digestion can then liberate the cDNA genome fragment without altering the viral genome 141 sequence. These cDNA fragments are ligated together and in vitro transcribed to form a viral 142 genome RNA that can now be transfected into cells with the N gene (either independently 143 expressed or as transcribed RNA) and a recombinant virus can be generated. This system 144 requires more in vitro manipulation to generate a full length cDNA that can be used for 145 transcription. However, the maintenance of the genome in multiple fragments facilitates the 146 manipulation of the genome. 147
Betacoronaviruses as Models 148
By comparing the members of the betacoronavirus group we can identify shared 149 mechanisms of lung injury that occur during betacoronavirus infection. Virus-unique 150 contributions and mechanisms of pathogenesis, such as the contribution of the interaction of the 151 spike protein with its cognate receptor to disease, can also be identified and studied. Both 152 SARS-CoV and MHV are members of the betacoronavirus genus. However, the specific organ 153 tropism of infection of many MHV strains makes them unsuitable as a model for SARS-CoV 154 infection. The most widely-studied strains, MHV-JHM and MHV-A59, primarily infect the 155 brain (MHV-JHM and MHV-A59) or liver (MHV-A59) (Weiss & Leibowitz, 2007) . The brain is 156 considered an immune-privileged site, thus cytokine/chemokine signaling and the cellular 157 response will not be the same as in a less privileged organ, like the lung. However MHV-1 is 158 pneumotropic (Leibowitz et al., 2010) and MHV-1 infected mice can serve as a mouse model for 159 severe respiratory coronavirus infections (see below). 160
Other betacoronaviruses have been used to dissect the function of SARS-CoV genes in 161 vitro and in vivo both by the study of homologous genes and by placing SARS-CoV proteins into 162 an MHV virus that does not express a homologue to the SARS-CoV gene (Hussain et al., 2008; 163 Kuri et al., 2011; Pewe et al., 2005; Tangudu et al., 2007) . One example is the study of nsp3, 164 which contains multiple functional domains, one of which is called the X domain (Kuri et al., 165 2011) . The X domain is a functional monophosphatase, called ADP-ribose-1"-pase (ADRP). shown to play a role in cytokine dysregulation (Law et al., 2007) , it is important to note that the 193 nsp1 of SARS-CoV is different, by sequence, and is shorter than the MHV nsp1. It is possible 194 that the differences in size are in nonfunctional regions or that the differences are purely host-195 related. However, it is also possible that these sequence differences reflect important functional 196 differences regarding the role of nsp1 in pathogenesis. 197
SARS-COV MODELS OF DISEASE 198
Recently a comparison of transcriptional profiles in human systemic inflammatory 199 diseases and the corresponding mouse models reported that transcriptional responses in murine 200 models were a poor mimic of the responses in human disease (Seok et al., 2013) . This 201 comparison was motivated by the poor success rate of drug trials moving from mouse to human. 202
Responses were similar between humans and mice at 6-12 hours. However, the overall recovery 203 time for genes to return to base line was drastically different in humans and mice. Relevant to 204 models of SARS, different mouse models of acute respiratory disease (ARD) had transcriptional 205 profiles which had R 2 correlations between 0 and 0.8, with 47-61% of the genes shifting in the 206 same direction, approximating that of random occurrence. Despite all the potential causes for 207 inconsistency in human responses (ie. age, different treatments, diseases /trauma severity) the 208 transcriptional profiles of human cases of ARD were highly consistent, with R 2 values of .55, 209 with 84% of the genes changing in the same direction. In the following sections we will examine 210 the validity of the animal model's response to SARS-CoV infection. 211
Animal Models of SARS-CoV 212
For some zoonotic diseases the natural host is unknown because these animals show no 213 signs or symptoms of illness, while in others disease in the natural host is mild and transient 214 The ability of the animal model to actually mimic the disease in humans is required, but 220 one must also consider the cost of experimentation and the ease of working with the animals. 221
Different species of animals have differing responses to coronavirus infection, and so the models 222 must be evaluated in terms of fitness compared to human SARS-CoV infection and disease 223 (Table 1 , a more complete review of pathology can be found in (van den Brand et al., 2014)). In 224 this section we will review the models that have been used in studying SARS-CoV disease 225 (Table 2) . Multiple passages in animals select for mutations that allow the virus to thrive in a specific 292 environment (Li, 2008; Zhang et al., 2006) . Adapted viruses are sequenced and then compared 293 with the parental genome to find mutations that occurred and to attempt to correlate them to the 294 adaptation. Because of adaptation mutations the virus may not utilize the same set of pathogenic 295 mechanisms as the parent virus does in humans. These viruses are also useful in conjunction 296 with transgenic animals. SARS-CoV has been adapted to mice and rats and the adapted viruses CoV Frankfurt strain (Nagata et al., 2008) . Clinical disease was observed only in aged animals 333 at day 2 post infection, with a mortality rate of 30-50%. Lungs from aged mice had significantly 334 higher IL-4 and lower IL-10 and IL-13 levels before infection than young mice, whereas lungs 335 from young mice contained not only proinflammatory cytokines but also IL-2, interferon-γ, IL-336 10, and IL-13. 337
The major drawback to the use of the MA15 or other mouse adapted SARS-CoV is the 338 requirement of older mice for the development of lethal disease. Aged animals are more difficult 339 to acquire in large numbers and they are more expensive than younger mice. 340
Rats have been used in ARDS and ACE2 studies, and seem a viable option for an animal 341 In hamsters low titers of virus were present in the liver and spleen at days 2 and 3 post infection, 361 but not thereafter. The animals developed a robust protective neutralizing antibody response by 362 day 7, one that the researchers report was more robust than the antibody response in mice. 363
Other studies used the golden Syrian hamster model to evaluate monoclonal antibody 364 therapy (Roberts et al., 2006) the study, blood chemistries and hemotologic parameters were largely unchanged. A second study with cynomolgus macaques demonstrated that infection with SARS-CoV did not produce 430 severe illness, but an illness similar to the milder SARS-CoV infections seen in younger children 431 (Lawler et al., 2006) . Infection of aged cynomolgus macaques did produce a disease that was 432 similar to the severe SARS-CoV illness seen in elderly patients (Smits et al., 2010) . Innate 433 immune responses in aged macques in response to SARS-CoV infection differed from the innate 434 responses of young animals (Smits et al., 2010). There were only 14 genes differentially 435 regulated, of 518 examined, between the two age groups. In aged macaques there was a more 436 robust induction of NF-κB regulated genes such as IL-6 than in young animals. STAT1 was 437 differentially expressed between the two age groups, with up-regulation in older animals whereas 438 it was not observed in younger animals. Another study used cynomolgus macaques to evaluate 439 It has been reported in MHV-1 susceptible mice that IFN-γ and TNF-α coproduction by CD8 T-474 cells is reduced in the lung compared to levels in B6 mice that do not develop lethal disease, but 475 not in the spleen or lymphoid tissues and that CD4 coproduction of IFN-γ and TNF-α is 476 increased in all tissues compared to B6 resistant mice (Khanolkar et al., 2010) . C3H/HeJ mice 477 also had a higher fraction of IFN-γ and IL-2 coproduction in spleen and draining lymph nodes, 478 but not in the lung, whereas B6 resistant mice produced more IL-2 in the lung than in the spleen. 479
The MHV-1 model has several advantages as a model for studying the pathogenesis of 480 coronavirus induced severe respiratory diseases. MHV-1 requires no BSL3 facilities, is a lower 481 risk pathogen than SARS-CoV, it naturally infects the lungs of mice, and creates a lethal SARS-482
CoV like disease in a specific mouse strain (A/J) while still causing non-lethal lung disease in 483 other strains. Because MHV-1 produces a non-lethal pulmonary infection in most strains, 484 various mouse strains can be used to evaluate gain of function or effect of genes in mutated or 485 recombinant MHV-1 viruses and to interrogate the role of specific host genes. However, the 486 MHV-1 model also has admitted limitations. The absence of exact copies of SARS-CoV 487 specific genes makes it difficult to evaluate those genes' role in pathogenesis. To date no 488 complete reverse genetic system is available for MHV-1, however there is a targeted 489 recombination system that could be used to introduce some of the specific SARS-CoV genes into 490 MHV-1and study their effect on pathogenesis in this model (Leibowitz et al., 2010) . Another 491 issue is the different receptors utilized by cell entry by the two viruses. SARS-CoV utilizes 492 ACE2 and thus impacts a major signaling cascade that is not affected in the MHV-1 model. 493
CONCLUSIONS 494
Animal models will likely not be able to completely recapitulate disease and pathology 495 that occurs during infection of humans with SARS-CoV. Models should be able to accurately 496 represent what occurs in human and should be able to do so in a manner that is safe for 497 researchers and that is not overly expensive. While primate models of disease are, generally, 498 considered to accurately mimic human disease they are expensive and difficult to handle. 499 Smaller mammals are safer and less expensive to work with and house, but usually require host-500 adapted viruses to recapitulate human disease. These models still require BSL3 containment to 501 work with them safely. Related coronaviruses that are non-infectious to humans that naturally 502 infect a small mammal are ideal in terms of cost and safety. However, a recent publication has 503 called into question the relevance of much of the mouse data regarding human inflammatory 504 diseases (Seok et al., 2013) . Thus, differences between humans and mice can make 505 understanding the pathogenesis of SARS-CoV difficult. However, we have demonstrated that the 506 models of SARS-CoV do, in part, mimic the disease course that is seen in humans not only in 507 terms of cytokine/chemokine response, but also in histology and cellular pathology. 508
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